-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Non-alcoholic fatty liver (NAFLD) is the main cause of chronic liver disease in pediatric age groups, especially in Western countries
Non-alcoholic fatty liver (NAFLD) is the main cause of chronic liver disease in pediatric age groups, especially in Western countries
child
In this observational study, the researchers included all children with non-alcoholic fatty liver
The results of the study showed that changes in children's systemic inflammation markers were found in both the placebo (Pla) group and the HXT+VitE treatment group
This study confirmed that children with NAFLD who received the combined treatment of HXT and VitE significantly reduced systemic inflammation, and its manifestation was mainly through increasing IL-10 circulating levels in response to DNA damage recovery, and ultimately improving steatosis and hypertriglyceridemia
This study confirmed that children with NAFLD who received the combined treatment of HXT and VitE significantly reduced systemic inflammation, and its manifestation was mainly through increasing IL-10 circulating levels in response to DNA damage recovery, and ultimately improving steatosis and hypertriglyceridemia
AntonellaMosca.
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
Leave a message here